Martin Brudermüller Is new CEFIC President

Martin Brudermüller, CEO of BASF, has been elected president of the European Chemical Industry Council (CEFIC) for a two-year term. In the rotating position, the 59-year-old German national, a native of Stuttgart, succeeds Daniele Ferrari, CEO of Versalis, who has held the position since October 2018.

In addition to heading the BASF board of executive directors since 2018, Brudermüller has been Chief Technology Officer of the Ludwigshafen chemical group – Europe’s and the world’s largest – since 2015.

Announcing the changing of the guard, CEFIC’s director general, Marco Mensink, said that with more than 30 years’ experience in various roles in the chemical industry, Brudermüller “will be able to lead us to deliver on the Green Deal objectives. Additionally, his strong belief in cooperation with stakeholders will help the industry association to continue to act as a dialogue partner with the European institutions and societal actors.”

In his acceptance remark, Brudermüller said, “it is my ambition during my presidency that the European Chemical Industry strikes a Future Chemistry Deal in the framework of the Green Deal – where we deliver technologies and solutions and the political framework enables their economical implementation.”

 

Author: Dede Williams, Freelance Journalist

„Hauptgrund für diese deutliche Steigerung war eine gute...
„Hauptgrund für diese deutliche Steigerung war eine gute Geschäftsentwicklung im September“, so BASF-Vorstandsvorsitzender Martin Brudermüller. © BASF

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

most read

Photo
29.10.2024 • News

GSK to Invest $800 Million in US Manufacturing Facility

British pharma company GlaxoSmithKline (GSK) plans to invest up to $800 million to expand drug substance and drug product manufacturing capabilities at the company’s US site in Marietta, Pennsylvania. The investment, which GSK said is its largest ever in US manufacturing, is expected to create more than 200 new jobs.

Photo
19.03.2025 • NewsInnovation

Data-Driven Enzyme Immobilization

Inseit, based in Bern, develops biocatalysts for industrial setups using enzyme immobilization and biocomputation. Addressing biotech and sustainability challenges, Inseit was selected for Venture Leaders Biotech and won two Nucleate accelerator prizes.